Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

Second-generation drug-eluting absorbable metal scaffold target-lesion revascularization: an optical coherence tomography case series study and literature review.

Ortega-Paz L, Brugaletta S, Gomez-Lara J, Sanchis J, Fernández-Díaz JA, Artaiz-Urdaci M, Alfonso F, Garcia-Garcia HM, Sabaté M.

EuroIntervention. 2019 Sep 3. pii: EIJ-D-19-00421. doi: 10.4244/EIJ-D-19-00421. [Epub ahead of print] No abstract available.

2.

Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention?

Costa F, Brugaletta S, Pernigotti A, Flores-Ulmanzor E, Ortega-Paz L, Cequier A, Iniguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, van Es GA, Backx B, Valgimigli M, Serruys P, Sabaté M.

Circ Cardiovasc Interv. 2019 Sep;12(9):e007705. doi: 10.1161/CIRCINTERVENTIONS.118.007705. Epub 2019 Aug 27.

PMID:
31451013
3.

Safety and outcomes of MitraClip implantation in functional mitral regurgitation according to degree of left ventricular dysfunction.

Sanchis L, Freixa X, Regueiro A, Perdomo JM, Sabaté M, Sitges M.

Rev Esp Cardiol (Engl Ed). 2019 Aug 9. pii: S1885-5857(19)30181-1. doi: 10.1016/j.rec.2019.06.002. [Epub ahead of print] English, Spanish.

PMID:
31405796
4.

BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial.

Chang CC, Kogame N, Asano T, von Birgelen C, Sabaté M, Onuma Y, Serruys PW.

EuroIntervention. 2019 Jul 30. pii: EIJ-D-19-00566. doi: 10.4244/EIJ-D-19-00566. [Epub ahead of print] No abstract available.

5.

Intravenous Statin Administration During Ischemia Exerts Cardioprotective Effects.

Mendieta G, Ben-Aicha S, Casani L, Badimon L, Sabaté M, Vilahur G.

J Am Coll Cardiol. 2019 Jul 23;74(3):475-477. doi: 10.1016/j.jacc.2019.05.020. No abstract available.

PMID:
31319923
6.

Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study.

Ibáñez L, Sabaté M, Vidal X, Ballarin E, Rottenkolber M, Schmiedl S, Heeke A, Huerta C, Martin Merino E, Montero D, Leon-Muñoz LM, Gasse C, Moore N, Droz C, Lassalle R, Aakjaer M, Andersen M, De Bruin ML, Groenwold R, van den Ham HA, Souverein P, Klungel O, Gardarsdottir H.

Br J Clin Pharmacol. 2019 Jul 18. doi: 10.1111/bcp.14071. [Epub ahead of print]

PMID:
31318059
7.

Minimally Invasive Transradial Percutaneous Closure of an Aortic Paravalvular Leak After Transcatheter Aortic Valve Replacement.

Ortega-Paz L, Regueiro A, Perdomo JM, Sanchis L, Sabaté M, Freixa X.

Can J Cardiol. 2019 Jul;35(7):941.e1-941.e2. doi: 10.1016/j.cjca.2019.04.025. Epub 2019 May 7. No abstract available.

PMID:
31292099
8.

Spontaneous coronary artery dissection: Not so infrequent to be ignored.

Cepas-Guillén PL, Flores-Umanzor E, Sabate M, Masotti M.

Med Clin (Barc). 2019 Sep 27;153(6):245-249. doi: 10.1016/j.medcli.2019.02.022. Epub 2019 Jun 20. English, Spanish. No abstract available.

PMID:
31230806
9.

A randomized comparison of the coronary vasomotor function and myocardial flow in patients treated with everolimus-eluting bioresorbable scaffolds and everolimus-eluting metallic stents.

Gomez-Lara J, Salvatella N, Romaguera R, Brugaletta S, Ñato M, Roura G, Ferreiro JL, Teruel L, Gracida M, Sabate M, Vaquerizo B, Cequier À, Gomez-Hospital JA; Collaborators.

EuroIntervention. 2019 Jun 18. pii: EIJ-D-18-01203. doi: 10.4244/EIJ-D-18-01203. [Epub ahead of print]

10.

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial.

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Asano T, Katagiri Y, van Geuns RM, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber CK, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek JJ, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys PW.

EuroIntervention. 2019 Aug 9;15(6):e539-e546. doi: 10.4244/EIJ-D-19-00184.

11.

The art of educating a fellow: a "mother-and-child" relationship.

Sabaté M.

EuroIntervention. 2019 May 20;15(1):17-19. doi: 10.4244/EIJV15I1A2. No abstract available.

12.

Unravelling the pathophysiology of spontaneous coronary artery dissections.

Sabaté M.

Rev Esp Cardiol (Engl Ed). 2019 Aug;72(8):604-605. doi: 10.1016/j.rec.2019.02.017. Epub 2019 May 14. English, Spanish. No abstract available.

PMID:
31101558
13.

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.

Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, Kaiser C, Remkes W, Räber L, de Belder A, van 't Hof AWJ, Stankovic G, Lemos PA, Wilsgaard T, Reifart J, Rodriguez AE, Ribeiro EE, Serruys PWJC, Abizaid A, Sabaté M, Byrne RA, de la Torre Hernandez JM, Wijns W, Jüni P, Windecker S, Valgimigli M; Coronary Stent Trialists' Collaboration.

Lancet. 2019 Jun 22;393(10190):2503-2510. doi: 10.1016/S0140-6736(19)30474-X. Epub 2019 May 2. Erratum in: Lancet. 2019 Jun 22;393(10190):2492.

PMID:
31056295
14.

Recurrent atherosclerosis complications as a mechanism for stent failure.

Andreou I, Stone PH, Ikonomidis I, Alexopoulos D, Sabaté M.

Hellenic J Cardiol. 2019 Apr 26. pii: S1109-9666(19)30121-6. doi: 10.1016/j.hjc.2019.04.007. [Epub ahead of print] Review.

15.

Multivessel spontaneous coronary artery dissection involving the left main coronary artery: a case report.

Cepas-Guillén PL, Flores-Umanzor EJ, Sabate M, Masotti M.

Eur Heart J Case Rep. 2019 Jan 12;3(1):yty168. doi: 10.1093/ehjcr/yty168. eCollection 2019 Mar.

16.

The MASTER trial: a new version of the oculostenotic reflex.

Sabaté M.

EuroIntervention. 2019 Apr 5;14(18):e1806-e1808. doi: 10.4244/EIJV14I18A316. No abstract available.

17.

How to SORT OUT an Additional Value From Noninferiority Stent Comparisons?

Brugaletta S, Sabaté M.

JACC Cardiovasc Interv. 2019 Apr 8;12(7):634-636. doi: 10.1016/j.jcin.2019.01.228. No abstract available.

PMID:
30947937
18.

Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.

Milojevic M, Serruys PW, Sabik JF 3rd, Kandzari DE, Schampaert E, van Boven AJ, Horkay F, Ungi I, Mansour S, Banning AP, Taggart DP, Sabaté M, Gershlick AH, Bochenek A, Pomar J, Lembo NJ, Noiseux N, Puskas JD, Crowley A, Kosmidou I, Mehran R, Ben-Yehuda O, Généreux P, Pocock SJ, Simonton CA, Stone GW, Kappetein AP.

J Am Coll Cardiol. 2019 Apr 9;73(13):1616-1628. doi: 10.1016/j.jacc.2019.01.037.

PMID:
30947913
19.

Impact of revascularization versus medical therapy alone for chronic total occlusion management in older patients.

Flores-Umanzor EJ, Vázquez S, Cepas-Guillen P, Ivey-Miranda J, Caldentey G, Jimenez-Britez G, Regueiro A, Freixa X, Andrea R, Ferreira-González I, Sabaté M, Martin-Yuste V.

Catheter Cardiovasc Interv. 2019 Mar 3. doi: 10.1002/ccd.28163. [Epub ahead of print]

PMID:
30828975
20.

Study of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use?

Gomez-Lumbreras A, Ferrer P, Ballarín E, Sabaté M, Vidal X, Andretta M, Coma A, Ibáñez L.

J Affect Disord. 2019 Apr 15;249:278-285. doi: 10.1016/j.jad.2019.01.039. Epub 2019 Feb 6.

PMID:
30784725
21.

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials.

Cassese S, Katagiri Y, Byrne RA, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz KL, Windecker S, Kastrati A, Serruys PW.

EuroIntervention. 2019 Feb 5. pii: EIJ-D-18-01080. doi: 10.4244/EIJ-D-18-01080. [Epub ahead of print]

22.

Comparison of the Frequency of Thrombocytopenia After Transfemoral Transcatheter Aortic Valve Implantation Between Balloon-Expandable and Self-Expanding Valves.

Hernández-Enríquez M, Chollet T, Bataille V, Campelo-Parada F, Boudou N, Bouisset F, Grunenwald E, Porterie J, Freixa X, Regueiro A, Sabaté M, Carrié D, Marcheix B, Lhermusier T.

Am J Cardiol. 2019 Apr 1;123(7):1120-1126. doi: 10.1016/j.amjcard.2018.12.036. Epub 2019 Jan 4.

PMID:
30709598
23.

Impact of post-procedural minimal stent area on 2-year clinical outcomes in the SYNTAX II trial.

Katagiri Y, De Maria GL, Kogame N, Chichareon P, Takahashi K, Chang CC, Modolo R, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, West NEJ, Piek JJ, Wykrzykowska JJ, Farooq V, Escaned J, Banning AP, Onuma Y, Serruys PW.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):E225-E234. doi: 10.1002/ccd.28105. Epub 2019 Jan 31.

PMID:
30702187
24.

Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.

Garcia-Lunar I, Pereda D, Santiago E, Solanes N, Nuche J, Ascaso M, Bobí J, Sierra F, Dantas AP, Galán C, San Antonio R, Sánchez-Quintana D, Sánchez-González J, Barberá JA, Rigol M, Fuster V, Ibáñez B, Sabaté M, García-Álvarez A.

Basic Res Cardiol. 2019 Jan 11;114(2):5. doi: 10.1007/s00395-018-0714-x.

PMID:
30635778
25.

MitraClip® Repair in Cardiogenic Shock Due to Acute Mitral Regurgitation: From Near-Death to Walking.

Hernández-Enríquez M, Freixa X, Sanchis L, Regueiro A, Burgos F, Navarro R, Masotti M, Sitges M, Sabaté M.

J Heart Valve Dis. 2018 Jan;27(1):114-116.

PMID:
30560609
26.

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial).

Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen LO, Cequier À, Hofma SH, Christiansen EH, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys PW.

EuroIntervention. 2018 Dec 7;14(11):e1224-e1226. doi: 10.4244/EIJ-D-18-00839. No abstract available.

27.

Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study.

Hioki H, Brugaletta S, Ishida K, Campo G, Biscaglia S, Ortega-Paz L, Cortese B, Varricchio A, Latib A, Sabaté M, Tespili M, Ielasi A.

EuroIntervention. 2019 May 20;15(1):108-115. doi: 10.4244/EIJ-D-18-00504.

28.

Percutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases.

Flores-Umanzor E, Martin-Yuste V, Caldentey G, Vazquez S, Jimenez-Britez G, San Antonio R, Cepas-Guillen P, Pujol-Lopez M, Hernández M, Sabaté M.

Rev Port Cardiol. 2018 Oct;37(10):865.e1-865.e4. doi: 10.1016/j.repc.2017.03.015. Epub 2018 Oct 21. English, Portuguese.

29.

Discovery of a Novel Inhaled PI3Kδ Inhibitor for the Treatment of Respiratory Diseases.

Erra M, Taltavull J, Bernal FJ, Caturla JF, Carrascal M, Pagès L, Mir M, Espinosa S, Gràcia J, Domínguez M, Sabaté M, Paris S, Maldonado M, Hernández B, Bravo M, Calama E, Miralpeix M, Lehner MD, Calbet M.

J Med Chem. 2018 Nov 8;61(21):9551-9567. doi: 10.1021/acs.jmedchem.8b00873. Epub 2018 Oct 29.

PMID:
30351000
30.

Latest STEMI treatment: a focus on current and upcoming devices.

Moscarella E, Brugaletta S, Sabaté M.

Expert Rev Med Devices. 2018 Nov;15(11):807-817. doi: 10.1080/17434440.2018.1538778. Epub 2018 Oct 30. Review.

PMID:
30343595
31.

The future of vascular restoration therapy.

Sabaté M.

EuroIntervention. 2018 Oct 12;14(9):e976-e979. doi: 10.4244/EIJV14I9A176. No abstract available.

32.

Thrombectomy and Stroke: Guilty or Innocent Bystander?

Sabaté M, Brugaletta S.

J Am Coll Cardiol. 2018 Oct 2;72(14):1597-1599. doi: 10.1016/j.jacc.2018.07.048. No abstract available.

PMID:
30261960
33.

Thrombocytopenia after transcatheter aortic valve implantation. A comparison between balloon-expandable and self-expanding valves.

Hernández-Enríquez M, Regueiro A, Romaguera R, Andrea R, Gómez-Hospital JA, Pujol-López M, Ferreiro-Gutiérrez JL, Brugaletta S, Roura G, Freixa X, Gómez-Lara J, Martín-Yuste V, Gracida M, Cequier Á, Sabaté M.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1344-1351. doi: 10.1002/ccd.27907. Epub 2018 Sep 23.

PMID:
30244545
34.

MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.

Brugaletta S, Cequier A, Alfonso F, Iñiguez A, Romaní S, Serra A, Salinas P, Goicolea J, Bordes P, Del Blanco BG, Hernández-Antolín R, Pernigotti A, Gómez-Lara J, Sabaté M.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):64-70. doi: 10.1002/ccd.27825. Epub 2018 Sep 9.

PMID:
30196572
35.

Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial.

Brugaletta S, Gomez-Lara J, Caballero J, Ortega-Paz L, Teruel L, Fernandez MJ, Romaguera R, Martinez VA, Ñato M, Navarro EM, Gomez-Hospital JA, Vilches CC, Joyera M, Cequier A, Angiolillo DJ, Sabate M.

Am Heart J. 2018 Oct;204:205-209. doi: 10.1016/j.ahj.2018.07.013. Epub 2018 Aug 2.

PMID:
30149889
36.

Angiographic late lumen loss revisited: impact on long-term target lesion revascularization.

Asano T, Serruys PW, Collet C, Miyazaki Y, Takahashi K, Chichareon P, Katagiri Y, Modolo R, Tenekecioglu E, Morel MA, Garg S, Wykrzykowska J, Piek JJ, Sabate M, Morice MC, Chevalier B, Windecker S, Onuma Y.

Eur Heart J. 2018 Sep 21;39(36):3381-3389. doi: 10.1093/eurheartj/ehy436.

PMID:
30124834
37.

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial.

Schur N, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Ademi Z, Schwenkglenks M, Sabaté M.

PLoS One. 2018 Aug 16;13(8):e0201985. doi: 10.1371/journal.pone.0201985. eCollection 2018.

38.

Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.

Serruys PW, Cavalcante R, Collet C, Kappetein AP, Sabik JF 3rd, Banning AP, Taggart DP, Sabaté M, Pomar J, Boonstra PW, Lembo NJ, Onuma Y, Simonton CA, Morice MC, McAndrew T, Dressler O, Stone GW.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1234-1243. doi: 10.1016/j.jcin.2018.03.051.

39.

Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry.

Amat-Santos IJ, Martin-Yuste V, Fernández-Díaz JA, Martin-Moreiras J, Caballero-Borrego J, Salinas P, Ojeda S, Rivero F, Núñez Villota J, Mohandes M, Dubois D, Bosa Ojeda F, Rumiz E, de la Torre Hernández JM, Jiménez-Mazuecos J, Lacunza J, Tejedor P, Gómez I, Goncalves-Ramirez LR, Rojas P, Sabaté M, Goicolea J, Diego Nieto A, Jiménez-Fernández M, Escaned J, Gonzalo N, Pardo L, Cuesta J, Miñana G, Sanchis J, Rojas S, Millán R, Vaquerizo B, Rodríguez S, Lee DH, Morales FJ, Gutiérrez A, López M, Maristany J, Rondán J, Galeote G, Kabbanni Z, Rodríguez S, Teruel L, Sadaba M, Jurado A, Mainar V, Sánchez-Rubio J, Vinhas H, Fernandes R.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):373-382. doi: 10.1016/j.rec.2018.05.020. Epub 2018 Jun 25. English, Spanish.

PMID:
29954721
40.

Minimally-invasive Transesophageal Echocardiography for Left Atrial Appendage Occlusion With a Latest-generation Microprobe. Initial Experience.

Jiménez Brítez G, Sanchis L, Regueiro A, Sabate M, Sitges M, Freixa X.

Rev Esp Cardiol (Engl Ed). 2019 Jun;72(6):511-512. doi: 10.1016/j.rec.2018.05.016. Epub 2018 Jun 23. English, Spanish. No abstract available.

PMID:
29945824
41.

Thrombotic and Bleeding Events After Percutaneous Coronary Intervention in Out-of-hospital Cardiac Arrest With and Without Therapeutic Hypothermia.

García J, Jiménez-Brítez G, Flores-Umanzor E, Mendieta G, Freixa X, Sabaté M.

Rev Esp Cardiol (Engl Ed). 2019 May;72(5):433-435. doi: 10.1016/j.rec.2018.04.022. Epub 2018 May 26. English, Spanish. No abstract available.

PMID:
29807760
42.

Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II Trial.

Gomez-Lara J, Brugaletta S, Ortega-Paz L, Vandeloo B, Moscarella E, Salas M, Romaguera R, Roura G, Ferreiro JL, Teruel L, Gracida M, Windecker S, Serruys PW, Gomez-Hospital JA, Sabaté M, Cequier A.

JACC Cardiovasc Interv. 2018 Aug 27;11(16):1559-1571. doi: 10.1016/j.jcin.2018.04.026. Epub 2018 May 24.

43.

Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD.

Collet C, Miyazaki Y, Ryan N, Asano T, Tenekecioglu E, Sonck J, Andreini D, Sabate M, Brugaletta S, Stables RH, Bartorelli A, de Winter RJ, Katagiri Y, Chichareon P, De Maria GL, Suwannasom P, Cavalcante R, Jonker H, Morel MA, Cosyns B, Kappetein AP, Taggart DT, Farooq V, Escaned J, Banning A, Onuma Y, Serruys PW.

J Am Coll Cardiol. 2018 Jun 19;71(24):2756-2769. doi: 10.1016/j.jacc.2018.02.053. Epub 2018 May 22.

44.

Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: 5-Year Outcomes of the Randomized BIOFLOW-II Trial.

Lefèvre T, Haude M, Neumann FJ, Stangl K, Skurk C, Slagboom T, Sabaté M, Goicolea J, Barragan P, Cook S, Macia JC, Windecker S.

JACC Cardiovasc Interv. 2018 May 28;11(10):995-1002. doi: 10.1016/j.jcin.2018.04.014.

45.

The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.

Katagiri Y, Serruys PW, Macaya C, Ormiston JA, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Wykrzykowska JJ, Piek JJ, Sabaté M, Windecker S, Chevalier B, Onuma Y.

JACC Cardiovasc Interv. 2018 May 28;11(10):1013-1015. doi: 10.1016/j.jcin.2018.02.020. No abstract available.

46.

Prevalence of use of antipsychotic drugs in the elderly in Catalonia.

Asensio C, Escoda N, Sabaté M, Carbonell P, López P, Laporte JR.

Eur J Clin Pharmacol. 2018 Sep;74(9):1185-1186. doi: 10.1007/s00228-018-2469-6. Epub 2018 May 23. No abstract available.

PMID:
29796874
47.

Cell-free DNA and Microvascular Damage in ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.

Sanchis J, García-Blas S, Ortega-Paz L, Dantas AP, Rodríguez E, Abellán L, Brugaletta S, Valero E, Miñana G, Garabito M, Corchón Á, Núñez J, Carratalá A, Sabaté M.

Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):317-323. doi: 10.1016/j.rec.2018.03.005. Epub 2018 Apr 11. English, Spanish.

PMID:
29655768
48.

New percutaneous interventions in heart failure.

Moscarella E, Brugaletta S, Sabaté M.

Minerva Cardioangiol. 2019 Apr;67(2):145-162. doi: 10.23736/S0026-4725.18.04686-8. Epub 2018 Apr 12. Review.

PMID:
29651826
49.

Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry Results.

Ellis SG, Gori T, Serruys PW, Nef H, Steffenino G, Brugaletta S, Munzel T, Feliz C, Schmidt G, Sabaté M, Onuma Y, van Geuns RJ, Gao RL, Menichelli M, Kereiakes DJ, Stone GW, Testa L, Kimura T, Abizaid A.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):638-644. doi: 10.1016/j.jcin.2017.11.042.

50.

Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial).

Spitaleri G, Brugaletta S, Scalone G, Moscarella E, Ortega-Paz L, Pernigotti A, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M.

Am J Cardiol. 2018 May 1;121(9):1039-1045. doi: 10.1016/j.amjcard.2018.01.015. Epub 2018 Feb 7.

PMID:
29544865

Supplemental Content

Loading ...
Support Center